id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2008-P-0647-0006,FDA,FDA-2008-P-0647,"Lachman Consultant Services, Inc., Consultants to the Pharmaceutical and Allied Industries - Withdrawal",Other,WDL-Withdrawal,2010-10-29T04:00:00Z,2010,10,2010-10-29T04:00:00Z,,2013-07-27T23:28:34Z,,0,0,0900006480b369c2
FDA-2008-P-0647-0003,FDA,FDA-2008-P-0647,"Attachment 1 - Clinoril® (Sulindac, 200mg Tablets) Product Description - [Lachman Consultant Services, Inc. - Citizen Petition]",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2008-12-24T05:00:00Z,2008,12,,,2008-12-24T15:06:35Z,,0,0,09000064807d93bb
FDA-2008-P-0647-0004,FDA,FDA-2008-P-0647,"Attachment 2 - Product Description - Sulindac Capsules (Sulindac) - [Lachman Consultant Services, Inc. - Citizen Petition]",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2008-12-24T05:00:00Z,2008,12,,,2008-12-24T15:06:37Z,,0,0,09000064807d93dc
FDA-2008-P-0647-0005,FDA,FDA-2008-P-0647,"Attachment 3 - Approved Drug Products with Therapeutic Equivalence Evaluations, 28th Edition - [Lachman Consultant Services, Inc. - Citizen Petition]",Supporting & Related Material,CP-Citizen Petition (Supporting & Related Materials),2008-12-24T05:00:00Z,2008,12,,,2008-12-24T15:06:38Z,,0,0,09000064807d9426
FDA-2008-P-0647-0001,FDA,FDA-2008-P-0647,"Lachman Consultant Services, Inc. - Citizen Petition",Other,CP-Citizen Petition,2008-12-17T05:00:00Z,2008,12,2008-12-17T05:00:00Z,2009-02-09T04:59:59Z,2013-07-27T22:33:15Z,,0,0,09000064807d8dae
FDA-2008-P-0647-0002,FDA,FDA-2008-P-0647,"Acknowledgement Letter to Lachman Consultant Services, Inc.",Other,ACK-Acknowledgement Letter,2008-12-17T05:00:00Z,2008,12,2008-12-17T05:00:00Z,,2013-07-27T22:33:16Z,,0,0,09000064807d8e54